CD44 and nonpapillary renal cell carcinoma: To validate CD44 expression in clinical samples of ccRCC, we conducted an analysis of CD44 mRNA expression in a human ccRCC cDNA array (n = 15) and assessed CD44 protein expression levels in paired ccRCC tissues and adjacent tissues (n = 12) obtained from advanced ccRCC patients.